
簡要描述:Cinnarizine 298-57-7Cinnarizine is a drug derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker
產(chǎn)品分類
Product Category詳細(xì)介紹
| 品牌 | absin | CAS | 298-57-7 |
|---|---|---|---|
| 分子式 | C26H28N2 | 純度 | >98% |
| 分子量 | 368.51 | 貨號 | abs47027377 |
| 規(guī)格 | 100mg | 供貨周期 | 現(xiàn)貨 |
| 主要用途 | is a drug derivative of piperazine, | 應(yīng)用領(lǐng)域 | 化工,生物產(chǎn)業(yè),農(nóng)林牧漁,制藥/生物制藥,綜合 |
Cinnarizine 298-57-7
| 產(chǎn)品描述 | |
| 描述 | Cinnarizine is a drug derivative of piperazine, and characterized as an antihistamine and a calcium channel blocker, it is also known to promote cerebral blood flow, and so is used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis. |
| 純度 | >98% |
| 儲存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | 桂li嗪;Stugeron |
| 外觀 | White to off white powder |
| 可溶性/溶解性 | DMSO : 9.1 mg/mL (24.69 mM) |
| 生物活性 | |
| 靶點(diǎn) | Calcium channel,Histamine receptor |
| In vitro(體外研究) | Cinnarizine inhibits melanogenesis in B16 cells by a dose-dependent manner at the non-cytotoxic concentrations and is a histamine receptor antagonists. |
| In vivo(體內(nèi)研究) | Cinnarizine has anticonvulsive properties in rats and mice. It could provide a direct neuroprotective effect against the damaging influx of calcium and also prevent neuronal damage as a result of MES- and PTZ-induced seizures. Cinnarizine induces behavioural changes such as alopecia, bucolingual dyskinesia and reduction of motor activity in female parkin knock out (PK-KO) mice but not in wild-type (WT) controls.PK-KO mice have high striatal dopamine levels and increased dopamine metabolism in spite of low reduced tyrosine hydroxylase protein. Cinnarizine, which blocks dopamine receptors and increases dopamine release, further increased dopamine metabolism. Its half-life is 4 hours. |
| 參考文獻(xiàn) | |
| 參考文獻(xiàn) |
| 研究領(lǐng)域 | |
| 研究領(lǐng)域 | Immunology Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產(chǎn)品咨詢
